论文部分内容阅读
由于我国人口基数大,所以妊娠滋养细胞疾病和肿瘤病例数仍较多。总体来说国内外妇科肿瘤学术机构和医生对本类疾病重视程度,投入等均不及宫颈癌、卵巢癌和子宫内膜癌等肿瘤;研究人员也相对较少;也有学者认为化疗己能根治,所以有关诊治近20余年来基本延用国际妇产科联盟(FIGO)指南。然而,治疗效果并不完全理想,仍有许多临床治疗方案疗效并不令人满意,对诊断、评分、低危和髙危的界定等具体问题在实践中仍不明确、不清楚,存在疑惑和不同见解。为此,仍有必要结合国情进一步探讨。
Due to the large population base in our country, there are still more cases of gestational trophoblastic diseases and cancer cases. In general, academic institutions and doctors of gynecologic oncology at home and abroad pay more attention to this disease than those who have cervical cancer, ovarian cancer and endometrial cancer; researchers are also relatively few; some scholars think that chemotherapy can cure the disease The diagnosis and treatment of the past 20 years, the basic extension of the International Federation of Gynecology and Obstetrics (FIGO) guide. However, the effect of treatment is not completely satisfactory. There are still many clinical treatment programs that are unsatisfactory. Specific issues such as the definition of diagnosis, grading, low risk and critical risk remain unclear, unclear and doubtful in practice Different opinion. To this end, there is still a need to further explore the national conditions.